Сахарный Диабет

лящегося). При этом определяют, насколько плотно смыкаются суставные поверхности.

•Необходим осмотр и других суставов (локтевых, позвоночника, суставов стоп).

•Для документирования степени поражения пальцев рук применяется снятие отпечатков рук.

Профилактика и лечение ОПС

•Тщательный метаболический контроль может предупредить развитие ОПС.

•Терапия этого осложнения сахарного диабета до настоящего времени ограничивается попытками восстановить подвижность суставов посредством:

•физических упражнений;

•физиотерапевтических процедур (лазеротерапия и др.).

Лабораторные показатели

В таблице 9 приведены нормальные значения широко используемых лабораторных показателей. Значения даны в единицах, применяемых в медицинских учреждениях РФ и во многих странах. Отдельные величины могут варьировать в зависимости от метода определения и некоторых других факторов. Использовались общепринятые значения.

Таблица 9

Продолжение

ЛИТЕРАТУРА

Балаболкин М. И. Эндокринология, М., Универсум паблишинг, 1998. Балаболкин М. И. Диабетология, М., Медицина, 2000.

Балаболкин М. И., Клебанова Е. М., Креминская В. М. Влияние метформина («Polfa) на показатели перекисного окисления липидов у больных сахарным диабетом 2 типа // Клин. фармакология и терапия. – 2001. – №4. – с. 89-90.

Дедов И. И., Мельниченко Г. А., Фадеев В. В. Эндокринология, М., Медицина, 2000.

Дедов И. И., Балаболкин М. И., Марова Е. И. и др. Болезни органов эндокринной системы, М., Медицина, 2000.

Agren J. J., Valve R., Vidgren H et al. Postprandial lipemic response is modified by the polymorphism at codon 54 of the acid-binding protein 2 gene // Arterioscler. Thromb. Vasc. Biol. – 1998. – Vol. 18. – P. 1606-1611.

Almind K., Frederiksen S. K., Bernal D. et al. Search for variants of the gene-pro- moter and the potencial phosphotyrosine encoding sequence of the insulin receptor substrate-2 gene: evaluation of their relation with alterations in insulin secretion and insulin sensitivity // Diabetologia. – 1999. – Vol. 42, – 1244-1249.

Babadjanova G., Allolio B., Beuschlein F. et al. Polymorphism of the glycogen synthase gene and non-insulin-dependent diabetes mellitus in the Russian population // Metabolism. – 1997. – Vol. 46. – P. 121-125.

Babadjanova G., Reincke M., Mora P. et al. Polymorphism of the glucagons receptor gene and non-insulin-dependent diabetes mellitus in the Russian population // Exp. Clin. Endocrinol. Diabetes. – 1997. – Vol. 105. – P. 225-229.

Bernal D., Almind K., Yenush L. et al. Insulin receptor substrate -2 amino acid polymorphisms are not associated with random type 2 diabetes among Caucasians // Diabetes. – 1998. – Vol. 47. – P. 976-979.

Brockley M., and Schneider R. L. The onset of blood glucose response in patients with type 2 diabetes treated with pioglitazone. // Diabetes.- 2000.- Vol. 49, Suppl 1.- A99, P. 400.

Cassell P. G., Jackson A. E., Evans J. C. et al. A haplotype combination of the calpain10 gene polymorphisms is a determinant of abnormal glucose tolerance in South Indians // Diabetes. – 2001. – Vol. 50. – Suppl. 2. – P. A28 (115-OR).

Chuang L. M., Lee K. C., Huang C. N. et al. Role of S20G mutation of amylin gene in insulin secretion, insulin sensitivity, and type II diabetes mellitus in Taiwanese patients // Diabetologia. – 1998. – Vol.41. P. 1250-1251.

Dalgaard L. T., Hansen T., Urhammer S. A. et al. Intermediate expansions of a GAA repeat in the frataxin gene are not association with type 2 diabetes or altered

glucose-induced beta-cell function in Danish Caucasians // Diabetes. – 1999. – Vol.

48.– 914-919.

Edwards G. and Eckland D. Pharmacokinetics of pioglitazone in patients with

renal impairment. //Diabetologia.- 1999.- Vol. 42, Suppl 1.- A230, P. 863.

Elbein S. C., Sun J., Scroggin E. et al. Role of common sequence variants in insulin secretion in familial type 2 diabetic kindreds // Diabetes Care/ – 2001. – Vol. 24. – P. 472-478.

Frayling T. M., Wiltshire S., Walker M et al. Genome wide linkage analyses in subsets of young onset type 2 diabetes families from the diabetes (UK) Warren2 sibpair repository loci on chromosome 1, 5, 8, 10 and 22 // Diabetes. – 2001. – Vol. 50. – Suppl. 2. – P. A28(113-OR).

Geerlof J. et Glazer B. Effect of food on the pharmacokinetics of pioglitazone. //Diabetologia.- 2000.- Vol. 43, Suppl 1.- A192, P.739.

Gora B. Pioglitazone is superior to acarbose in improving glycemic control and dyslipidemia in patients with type 2 diabetes – an interim analysis. // Diabetologia.- 2000.- Vol. 43, Suppl 1.- A193, P.740.

Gough S. C., Saker P. J., Pritchard L. E. et al. Mutation of the glucagons receptor gene and diabetes mellitus in the UK: association or founder effect? // Hum. Mol. Genet. – 1995. – Vol. 4. – P. 1609-1613.

Groop L. C., Kankuri M., Schalin-Jantti C et al. Association between polymorphism of the glycogen synthase gene and non-insulin-dependent diabetes mellitus // N. Engl. J. Med. – 1993. – Vol. 328 – P. 10-15.

Hager J., Hansen L., Vaisse C et al. A missense mutation in the glucagons receptor gene is associated with non-insulin-dependent diabetes mellitus // Nat. Genet. – 1995. – Vol. 9. – P. 299-303.

Hani E. H., Boutin P., Durand E et al. Missense mutations in the pancreatic islet beta cell inwardly rectifying K+ channel gene (Kir6.2/BIR): a meta-analysis suddests a role in the polygenic basis of type II diabetes in Caucasians // Diabetologia. – 1998.

– Vol. 41. – P. 1511-1515.

Hansen E. H., Echwald S. M., Hansen L. et al. Decreased tolbutamidestimulated insulin secretion in healthy subjects with sequence variants in the high-affinity sulfonylurea receptor gene // Diabetes. – 1998. – Vol. 47. – P. 598-601.

Hansen L., Fjordvang H., Rasmussen S. K. et al. Mutational analysis of the coding regions of the genes encoding protein kinase B-alpha and -beta, phosphoinositidedependent protein kinase-1, phosphatase targeting to glycogen, protein phosphatase ingibitor-1, and glycogenin: lessons from a serch for genetic variability of the insulinstimulated glycogen synthesis pathway of skeletal muscle in NIDDM pathients // Diabetes. – 1999. – Vol. 48. – 403-407.

Hansen L., Hansen T., Vestergaard Y et al. A widespread amino acid polymorphism at codon 905 of the glycogen-associated regulatory subunit of protein phos- phatase-1 is associated with insulin resistance and hypersecretion of insulin // Hum. Mol. Genet. – 1995. -Vol. 4. 1313-1320.

Hayakawa T., Nagai Y., Nohara E. et al. Variation of the fatty acid binding protein 2 gene is not associated with obesity and insulin resistance in Japanese subjects // Metabolism. – 1999. – Vol. 82. – P. 655-659.

Hayamawa T., Nagai Y., Ando N. et al. S 20G mutation of the amylin gene in Japanese patients with type 2 diabetes // Diabetes Res. Clin. Pract. – 2000. – Vol. 49.

– P. 195-197.

Hegele R. A., Harris S. B., Zinman B. et al. Variation in the AU(AT)-rich element within the 3'-untranslated region of PPP1R3 is associated with variation in plasma glucose in aboriginal Canadians // J. Clin. Endocrinol. Metab. – 1998. -Vol. 83. – P. 3980-3985.

Horikawa Y., Oda N., Cox N. J. et al. Genetic variation in the gene encoding cal- pain-10 is associated with type 2 diabetes mellitus // Nat. Genet. – 2000. – Vol. 26. – P. 163-175.

Huang C. N., Lee K. C., Wu H. P. et al. Screening for the Gly40Ser mutation in the glucagons receptor gene among patients with type 2 diabetes or essential hypertension in Taiwan // Pancreas. – 1999. – Vol. 18. – P. 151-155.

Huang X., Orho M., Lehto M., Groop L. Lack of association between the Gly40Ser polymorphism in the glucagons receptor gene and NNIDM in Finland // Diabetologia. – 1995. – Vol. 38. – P. 1246-1249.

Inoue H., Ferrer J. Welling C/ M. et al. Sequence variants in the sulfonylurea receptor (SUR) gene are associated with NIDDM in Caucasians // Diabetes. – 1996, – Vol. 45. – P. 825-826.

Jansen R. C., Bogardus C., Takeda J et al. Linkage analysis of acute insulin secretion with GLUT-2 and glucokinase in Pima Indians and identification of a missense mutation in GLUT-2 // Diabetes – 1994. – Vol. 43. – P. 558-591.

Ji L., Malecki M., Warram J. H. et al. New susceptibility locus for NIDDM is localized to human chromosome 20q // Diabetes. – 1997. – Vol. 46. – P. 876-881.

Kelly L. J.,Vicario P. P., Thompson G. M. et al. Peroxisome proliferator-activated receptorsandmediate in vivo regulation of uncoupling protein (UCP-1,UCP-2, UCP- 3) gene expression. //Endocrinology.- 1998.- Vol. 139.- P. 4920-4927.

Klupa T., Malecki M. T., Pezzolesi M et al. Further evidence for a susceptibility locus for type 2 diabetes on chromosome 20q13.1-q13.2.

Lepretre F., Vionnet N., Budhan S. et al. Genetic studies of polymorphism in ten non-insulin-dependent diabetes candidate genes in Tamil Indians from Pondichery // Diabetes Metab. – 1998. – Vol. 24. – P. 244-249.

Majer M., Mott D. M., Mochizuki H et al. Fssociation of the glycogen synthase locus on 19q13 with NIDDM jn Pima Indians // Diabetologia. – 1996. – Vol. 39. – P. 314-319.

Malecki M. T., Jhala U. S., Antonellis A et al. Mutation in BETA2/ NeuroD gene responcible for the development of type 2 diabetes mellitus // Diabetes. – 1999. – Vol.48. – P. A182.

Malecki M. T., Antonellis A., Casey P et al. Exclusion of the hepatocyte nuclear factor 4 as a candidate gene for late-onset NIDDM linked with chromosome 20q // Diabetes. – 1998. – Vol. 47. – P. 970-972.

Matsubara A., Wasson J. C., Donelan S. S. et al. Isolation and characterization of the human AKT1 gene, identification of 13 single nucleotide polymorphosms (SNPs) and their lack of association with type 2 diabetes // Diabetologia. – 2001. – Vol. 44. – P. 910-913.

McCarthy M. I., Hattersley A. T., Walker M et al. Genome scan linkage from a large European family collection supports localization of a type 2 diabetes susceptibility gene to chromosome 1q21-23 // Diabetes. – 2001. – Vol. 50. – Suppl. 2. – P. A27 (109-OR).

Mitchell B. D., Kammerer C. M., O'Connell P. et al. Evidence for linkage of postchallenge insulin levels with intestinal fatty acid-binding protein (FABP2) in Mexican-Americans // Diabetes. – 1995. – Vol. 44. – P. 1046-1051.

Ohagi S., Sakaguchi H., Sanke T. et al. Human prohormone convertase 3 gene: exon-intron organization and molecular scanning for mutations in Japanese subjects with NIDDM // Diabetes. – 1996. – Vol. 45. – P. 897-901.

Olansky L., Janssen R., Welling C., Permutt M. A. Variability of the insulin gene in American blacks with NIDDM. Analysis by single – strand conformational polymorphisms // Diabetes. – 1992. – Vol. 41. – P. 742-747.

Ong K. R., Phillips D. I., Fall C. et al. The insulin gene VNTR, type 2 diabetes and birth weight // Nat. Genet. – 1999. – Vol. 21. – P. 262-267.

Phillips D. I. Insulin resistance as a programmed response to fetal undernutrition // Diabetologia. – 1996. – Vol. 39. – P. 1119-1123.

Polonsky K. S., Given B. D., Hirsch L. J. et al. Quantitative study of insulin secretion and clearance in normal and obese subjects // J. Clin. Invest. 1988-vol. 81, 435441.

Prochazka M., Lillioja S., Tait J. F. et al. Linkage of chromosomal markers on 4q with a putative gene determining maximal insulin action in Pima Indians // Diabetes.

– 1993. – Vol. 42. – P. 514-517.

Rich S. S. Positional cloning works! Identification of genes that cause IDDM // Diabetes. – 1995. – Vol. 44. – P. 139-143.

Rissanen J., Pihlajamaki J., Heikkinen S et al. The Ala54Thr polymorphism of the fatty acid binding protein 2 gene does not influence insulin sensitivity in Finnish nondiabetic and NIDDM subjects // Diabetes. – 1997. – Vol. 46. – P. 711-715.

Ristow M., Giannakidou E., Hebinck J et al. An association between NIDDM and a GAA trinucleotide repeat polymorphism in the X25/frataxin (Friedreich's ataxia) gene // Diabetes. – 1998. – Vol. 47. – P. 851-856.

Rosenstock J. Improved insulin sensitivity and beta cell responsivity suggested by HOMA analysis of pioglitazone therapy. //Diabetologia.- 2000.- Vol.43, Suppl 1.- A192, P.738.

Sakagashira S., Sanke T., Hanabusa T et al. Missense mutation of amylin gene (S20G) in Japanese NIDDM patients – Diabetes. – 1996. – Vol. 45. – P. 1279-121281.

Schalin-Jantti C., Nikula-Ijas P., Huang X. et al. Polymorphism of the glycogen synthase gene in hypertensive and normotensive subjects // Hypertension. – 1996. – Vol. 27. – P. 67-72.

Seino S. S20G mutation of the amylin gene is associated with type 2 diabetes in Japanese // Diabetologia. – 2001. – V0l. 44. – P. 906-909.

Shaffer S., Rubin C. J., Zhu E. The effect of pioglitazone on the lipid profile in patients with type 2 diabetes. //Diabetes.- 2000.- Vol.49, Suppl 1.- A125, P.508.

Shen G. Q., Ikegami H., Kawaguchi Y et al. Asp 905 Tyr polymorphism of the gene for the skeletal muscle-specific glycogen-targeting subunit of protein phosphatase 1 in NIDDM // Diabetes Care. – 1998. – Vol. 21. – P. 1086-1089.

Shimomura H., Sanke T., Ueda K. et al. A missense mutation of the muscle glycogen synthase gene (M416V) is associated with insulin resistance in the Japanese population // Diabetologia. – 1997. – Vol. 40. – P. 947-951.

Silver K., Walston J., Wang Y et al. Molecular scanning for mutation in the beta 3-adrenergic receptor gene in Nauruans with obesity and non-insulin-dependent diabetes mellitus // J. Clin. Endocrinol. Metab. – 1996. – Vol. 81. – P. 4155-4159.

Stenbit A. E., Tsao T. S., Li J. GLUT-4 heterozygous knockout mice develop muscle insulin resistance and diabetes // Nat. Med. – 1997. – Vol. 3. – P. 1096-1999.

Stern M. P., Duggirala R., Mitchell B. D. et al. Evidence for linkage of regions on chromosome 6 and 11 to plasma glucose concentration in Mexican Americans // Genome Res. – 1996. – Vol. 6. P. 724-727.

Tanizawa Y., Riggs A. C., Chiu K.C. et al. Variability of the pancreatic islet beta cell/liver (GLUT-2) glucose transporter gene in NIDDM patients // Diabetologia. – 1994. – Vol. 37. – P. 420-423.

Tonolo G., Melis M. G., Ciccarese M. et al. Physiological and genetic characterization of the Gly40Ser mutation in the glucagons receptor gene in the Sardinian population. The Sardinian diabetes genetic study group // Diabetologia. – 1997. – Vol. 40.

– P. 89-92.